San Antonio, TX, United States of America

Elzbieta Izbicka

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 106(Granted Patents)


Company Filing History:


Years Active: 1995-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Elzbieta Izbicka: Innovator in Pharmaceutical Treatments

Introduction

Elzbieta Izbicka is a prominent inventor based in San Antonio, TX, known for her significant contributions to the field of pharmaceuticals. With a total of 13 patents to her name, she has made remarkable strides in developing innovative treatments for various medical conditions.

Latest Patents

Among her latest patents is a method for treating insulin resistance, which involves administering a pharmaceutical composition comprising diethyl azelate. This method allows for oral administration at a dosage range from about 0.1 mg/kg/day to about 10 mg/kg/day. Another notable patent focuses on dicarboxylic acid esters for treating diseases associated with phospholipase D toxin. This disclosure provides compositions and methods aimed at addressing conditions linked to PLD toxin through the administration of a dicarboxylic acid ester.

Career Highlights

Elzbieta has worked with several companies throughout her career, including Cancer Prevention and Cure, Ltd. and New Frontier Labs, LLC. Her work in these organizations has been instrumental in advancing research and development in the pharmaceutical sector.

Collaborations

Elzbieta has collaborated with notable professionals in her field, including Robert T Streeper and Sung H Baek. These partnerships have contributed to her innovative research and the successful development of her patented methods.

Conclusion

Elzbieta Izbicka's work exemplifies the impact of innovation in the pharmaceutical industry. Her dedication to developing effective treatments continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…